Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Annals of Surgical Oncology|March 18, 2026
Occult Nodal Disease in Gallbladder Cancer: An International Multi-institutional Analysis and Preoperative Risk StratificationJun Kawashima, Kizuki Yuza, Yutaka Endo, et al.Anticancer Research|January 25, 2023
Glasgow Prognostic Score Predicts Survival and Recurrence Pattern in Patients With Hepatocellular Carcinoma After HepatectomyTakafumi Kumamoto, Kazuhisa Takeda, Ryusei Matsuyama, et al.Medicine|August 3, 2019
Outcome of postoperative radiation therapy for cholangiocarcinoma and analysis of dose-volume histogram of remnant liverYuki Mukai, Ryusei Matsuyama, Izumi Koike, et al.Scientific Reports|November 13, 2025
Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1403 (C-FLAP study)Noritoshi Kobayashi, Yasuhiro Yabushita, Ryutaro Mori, et al.World Journal of Surgical Oncology|August 11, 2019
High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of VaterTakashi Murakami, Ryusei Matsuyama, Michio Ueda, et al.Journal of Surgical Oncology|October 14, 2024
Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study GroupKota Sahara, Diamantis I Tsilimigras, Yuki Homma, et al.Journal of Surgical Oncology|June 14, 2017
Neoadjuvant chemoradiotherapy of pancreatic cancer induces a favorable immunogenic tumor microenvironment associated with increased major histocompatibility complex class I-related chain A/B expressionTakashi Murakami, Yuki Homma, Ryusei Matsuyama, et al.European Journal of Nutrition|June 19, 2026
Glycemic index, glycemic load, and colorectal cancer risk stratified by insulin receptor expression: the Japan Public Health Center-based Prospective studyYuki Homma, Shiori Nakano, Kenshiro Nishihara, et al.Journal of Cellular Biochemistry|June 20, 2017
Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and Metastasis in a Syngeneic Pancreatic-Cancer Orthotopic Mouse ModelTakashi Murakami, Yukihiko Hiroshima, Yong Zhang, et al.Cancer Letters|August 3, 2020
Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse modelJun Yamamoto, Kentaro Miyake, Qinghong Han, et al.Pageof 7